AEZS stock

AEterna Zentaris Inc. (USA) (AEZS) Stock Fires Up to the Roof; Here’s Why

AEterna Zentaris Inc. (USA)(NASDAQ:AEZS) investors are busy throwing a party today following the news that tiny drug maker has sold its U.

Jason Kolbert Believes AEterna Zentaris Inc. (USA) (AEZS) Is “Deeply Undervalued;” Shares Leap 64% Following FDA Win for AGHD Drug

Maxim’s Jason Kolbert bets AEZS’ oral test could set a new standard in addressing Adult Growth Hormone Deficiency (AGHD) with FDA approval now under its belt.

AEterna Zentaris Inc. (USA) (AEZS) Investors Celebrate FDA Approval; Shares Skyrocket

Investors love biotech stocks for the lottery ticket-like returns they can offer if a company strikes medical gold or wins the regulator’s bless. …

Ahead of Big Catalyst, AEterna Zentaris Inc. (AEZS) Announced Departure of Interim Chief Financial Officer

December is an exciting month for AEterna Zentaris Inc. (NASDAQ:AEZS) investors, with the upcoming PDUFA on December 30 for Macrilen (macimorelin), for the evaluation …

AEterna Zentaris Inc.’s (USA) (AEZS) Growth Hormone Drug Accepted for EU Review

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) announced that the Marketing Authorization Application (MAA) for the use of Macrilen™ (macimorelin) for the evaluation of adult …

Company Update: AEterna Zentaris Inc. (AEZS) Announces 3Q:17 Highlights and Financial Results

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) reported financial and operating results for the third quarter ended September 30, 2017.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts